Equillium, Inc.
EQ- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001746466
No open-market purchases or sales by Equillium, Inc. insiders were filed in the last 90 days; 60 institutions reported holding it in 13F filings for Q2 2026, worth $133.0M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Equillium, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- −2 vs. Q2 2023
- Shares held
- 9.12M
- −799.1K (−8.1%) vs. Q2 2023
- Total value
- $6.75M
- −$690.2K (−9.3%) vs. Q2 2023
- New holders
- 1
- 6 more added
- Sold out
- 3
- 6 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EQ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 60 | $133.0M |
| Q1 2026 | 50 | $81.0M |
| Q4 2025 | 36 | $54.7M |
| Q3 2025 | 40 | $42.4M |
| Q2 2025 | 27 | $2.74M |
| Q1 2025 | 24 | $3.39M |
| Q4 2024 | 26 | $6.52M |
| Q3 2024 | 26 | $7.25M |
| Q2 2024 | 25 | $6.15M |
| Q1 2024 | 28 | $20.5M |
| Q4 2023 | 25 | $6.85M |
| Q3 2023 | 25 | $6.75M |
| Q2 2023 | 27 | $7.44M |
| Q1 2023 | 28 | $7.86M |
| Q4 2022 | 31 | $13.3M |
| Q3 2022 | 30 | $28.4M |
| Q2 2022 | 25 | $25.6M |
| Q1 2022 | 30 | $39.7M |
| Q4 2021 | 26 | $27.0M |
| Q3 2021 | 22 | $49.9M |
| Q2 2021 | 28 | $41.9M |
| Q1 2021 | 33 | $54.6M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Equillium, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Decheng Capital Management III (Cayman), LLC | 4,447,308 | $3.29M | 1.10% | 00.0% | Unchanged |
| Franklin Resources Inc | 895,000 | $662.3K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 873,609 | $646.5K | 0.00% | −317,716−26.7% | Reduced |
| Vanguard Group Inc | 836,930 | $619.3K | 0.00% | 00.0% | Unchanged |
| Cota Capital Management, LLC | 562,278 | $416.1K | 0.21% | 00.0% | Unchanged |
| Tang Capital Management LLC | 400,000 | $296.0K | 0.04% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 293,291 | $217.0K | 0.00% | −98,940−25.2% | Reduced |
| Geode Capital Management, LLC | 172,387 | $127.6K | 0.00% | +13,610+8.6% | Added |
| Bridgeway Capital Management, LLC | 125,500 | $92.9K | 0.00% | 00.0% | Unchanged |
| Callan Capital, LLC | 103,688 | $76.7K | 0.01% | 00.0% | Unchanged |
| DCF Advisers, LLC | 69,871 | $51.7K | 0.04% | −41,752−37.4% | Reduced |
| Prudential Financial Inc | 57,800 | $42.8K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 56,220 | $41.6K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 46,983 | $34.8K | 0.00% | +331+0.7% | Added |
| Integrated Wealth Concepts LLC | 40,000 | $29.6K | 0.00% | +8,661+27.6% | Added |
| Two Sigma Securities, LLC | 36,287 | $26.9K | 0.00% | +36,287 | New |
| Northern Trust Corp | 35,155 | $26.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 25,838 | $19.1K | 0.00% | −48,266−65.1% | Reduced |
| Capital CS Group, LLC | 19,000 | $14.1K | 0.02% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 9,892 | $7.32K | 0.00% | −2,627−21.0% | Reduced |
| BlackRock Inc. | 9,826 | $7.27K | 0.00% | +102+1.0% | Added |
| Simplex Trading, LLC | 2,073 | $1.00K | 0.00% | +3+0.1% | Added |
| Wells Fargo & Company | 1,139 | $843 | 0.00% | +3+0.3% | Added |
| Group One Trading, L.P. | 200 | $148 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 299 | $0 | 0.00% | −168−36.0% | Reduced |
| Deutsche Bank AG | 0 | $0 | 0.00% | −348,061−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −494−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −25−100.0% | Sold out |